InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Wednesday, 08/26/2020 6:08:14 AM

Wednesday, August 26, 2020 6:08:14 AM

Post# of 403222
preinfection data good the RBL told Leo and the world. Last PR was post infection inhibition by 50%???Not sure. Why isn't it clear? Something so simple,c'mon Leo and get it straight.

What impact cwill that have a hospitalized patient? Teeming with virus so you inhibit half? Is it at all worthwhile?

Why not announce a warp speed inhaler for prophylaxis project? Instead we will spend our money on a very uncertain IV B trial in the already infected hospital corona population. High risk high reward as has been well described here.

Will the FDA approve the trial? Why not? IV B was safe before and some data are in its favor. I am betting approval by aFDA and then trial failure.

Then perhaps a pivot to an inhaler, but will there be money?

Then back to B for UC but will there be money for a trial?

As someone who bought more shares when Leo trumpeted the initial data and talked up the pan corona grant, I feel used
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News